合肥立方制药股份有限公司2025年第二次临时股东会决议公告

Meeting Overview - The second extraordinary general meeting of Hefei Lifan Pharmaceutical Co., Ltd. was held on November 17, 2025, with a combination of on-site and online voting methods [3][8] - The meeting was convened by the company's board of directors and presided over by Chairman Ji Junqiu [4][5] Attendance and Voting - A total of 189 shareholders and their proxies attended the meeting, representing 120,229,876 shares, which is 63.2183% of the total voting shares [6] - Among them, 13 shareholders attended the meeting on-site, representing 106,381,385 shares (55.9366%), while 175 shareholders participated via online voting, representing 13,848,491 shares (7.2817%) [6] - Small and medium-sized shareholders accounted for 16,452,031 shares (8.6507%) of the total voting shares [7] Resolutions and Legal Compliance - No proposals were rejected during the meeting, and it did not involve changes to previously approved resolutions [8] - The meeting's procedures were confirmed to comply with the Company Law of the People's Republic of China and the company's articles of association, as verified by the witnessing lawyers [9] Documentation - The resolutions from the meeting and the legal opinion from Beijing Jingtian & Gongcheng Law Firm are available for review [10]